601567 三星医疗
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)10.40118.56310.3187.88911.267
总资产报酬率 ROA (%)5.53410.0886.0994.8326.851
投入资产回报率 ROIC (%)7.38013.4018.1346.1348.435

边际利润分析
销售毛利率 (%)34.61133.99128.88225.36828.736
营业利润率 (%)18.80019.80812.66612.12116.813
息税前利润/营业总收入 (%)20.18919.65712.49913.31518.090
净利润/营业总收入 (%)16.49316.75710.60710.07613.547

收益指标分析
经营活动净收益/利润总额(%)84.56575.13191.41159.36768.462
价值变动净收益/利润总额(%)5.78618.263-1.95636.37533.907
营业外收支净额/利润总额(%)3.175-0.371-0.026-0.521-0.336

偿债能力分析
流动比率 (X)1.4501.7851.4451.6331.599
速动比率 (X)0.9841.3091.1291.3951.455
资产负债率 (%)43.69948.15640.70739.86635.859
带息债务/全部投入资本 (%)17.17826.95213.81418.71420.076
股东权益/带息债务 (%)441.339247.302578.259415.457387.358
股东权益/负债合计 (%)126.798106.234143.897149.727175.527
利息保障倍数 (X)26.123-254.951-76.56610.59013.572

营运能力分析
应收账款周转天数 (天)67.09167.65580.78097.12690.961
存货周转天数 (天)129.732120.34982.12761.47747.123